氨酸在小鼠中引起隔膜神经肌肉结合形态的类似衰老的变化
Chloe I Gulbronson1, Sepideh Jahanian1, Heather M Gransee1
1Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Cells
|March 26, 2025
概括
克洛洛昆诱导的自功能障碍在成年小鼠中损害神经肌肉结 (NMJs),模仿衰老效应. 这项研究揭示了膜NMJ的结构变化和增加的化.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 衰老研究研究 衰老研究
背景情况:
- 自对于细胞健康至关重要,并且在衰老时受到损害.
- 衰老与神经肌肉衰退和运动神经元功能障碍有关.
- 自蛋白LC3和p62在宫运动神经元中随着年龄的增长而增加,这表明受损.
研究的目的:
- 为了研究自抑制对隔膜神经肌肉结 (NMJ) 形态和化的影响.
- 为了确定一种自抑制剂 - - 洛昆是否能模拟NMJ的与衰老相关的变化.
- 评估自在维持成年小鼠NMJ结构完整性的作用.
主要方法:
- 成年雄性和雌性小鼠每天在7天内内内注射克洛洛昆 (10mg/kg/d) 或载体.
- 使用膜肌肉NMJ检查了发动机端板 (α-bungarotoxin) 和前突触终端 (anti-synaptophysin) 的光标记.
- 使用共聚焦显微镜分析了前和后突触形态,并量化了化.
主要成果:
- 与对照人群相比,诺基因治疗显著减少了膜NMJs的12%的前突触终端体积 (p <0.05).
- 没有观察到 postsynaptic终端体积的显著变化.
- 诺基因的使用导致部分消神NMJ的2.7倍增加 (p < 0.05).
- 观察到的NMJs的形态变化与老年小鼠 (18个月大) 中发现的变化相似.
结论:
- 克洛洛因的自抑制会诱导成年小鼠膜膜NMJs的结构变化和部分变质.
- 这些发现表明,受损的自会导致NMJ功能障碍,类似于衰老过程.
- 自对于保持成年NMJs的结构完整性至关重要.
相关概念视频
Skeletal Muscle Relaxants: Adverse Effects
325
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
325
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
377
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
377
Myasthenia Gravis: Diagnostic Tests
581
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
581
Myasthenia Gravis: Overview and Treatment
1.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K
Chemical Synapses
8.6K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.6K
Depolarizing Blockers: Mechanism of Action
1.1K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.1K


